KATHOLIEKE UNIVERSITEIT LEUVEN;K U LEUVEN R&D;UCB PHARMA SPRL
发明人:
VANDERHOYDONCK BART,REUBERSON JAMES THOMAS,HUANG QIUYA
申请号：
AP2015008552
公开号：
AP2015008552A0
申请日:
2013.12.20
申请国别(地区):
AP
年份:
2015
代理人:
摘要：
A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders； viral diseases and malaria； and organ and cell transplant rejection.
